Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NeoGenomics Inc. Common Stock (NEO) vs US Bancorp (USB) Price & Performance

NeoGenomics Inc. Common StockTrade
US BancorpTrade

Price performance (Past 24H)

Key statistics

NeoGenomics Inc. Common Stock vs US Bancorp — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B), while US Bancorp trades at $56.26 (market cap $88.64B). The key difference: US Bancorp is far larger — about 41.4× NeoGenomics Inc. Common Stock's market cap, and US Bancorp pays a 3.8% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and US Bancorp for 98 Days on average.

NEOUSB
Market Cap
$2.14B$88.64B
Volume
2,228,4008,200,583
Sector
HealthFinancials
52-Week High
$19.91$65.42
52-Week Low
$7.19$45.47
Typical Hold Time
0 Days98 Days
Enterprise Value
$2.44B$118.14B
Dividend Yield
—3.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

US Bancorp

U.S. Bancorp (USB) trades at $56.89, down 0.92% with bearish technical signals but strong fundamentals including consistent earnings beats and a 27.61% net margin. The stock shows a P/E of 11.36 and ROE of 13.53%, with analyst consensus at Buy (51%) and a $69.94 price target. Recent news highlights dividend increases and strong Q3 expectations for net interest income and fee revenues.

Outlook remains positive based on valuation and earnings momentum, though risks include regulatory changes and interest rate sensitivity. The 3.8% dividend hike to $0.54 signals management confidence, but investors should monitor net cash flow trends and competitive pressures in regional banking.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEO
100% Buy0% Sell
Avg holding period · 0 Days
USB

No sentiment data available yet.

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →

About US Bancorp

As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.

Read more on USB →